Group
Rare Diseases
4 themes21 tickers
10D rank10D#167of 172 groups/172
Peek into the magic of rare disease healthcare. Our group splits into gene, RNA, and protein therapy themes, plus CNS/neuro breakthroughs. With supportive policies and expanding patient access, this market is buzzing with innovative platforms and growth.
Themes in this group
| Rare Diseases '25: RNA Therapy & Protein ModRNA Therapy & Protein Mod | 5 | $9.73B | $48.63B | -0.07% | -3.35% | -13.25% | -0.54% | -27.01% | -13.04% | +5.86% | +241.27% | -20.06% | -6.22% | -18.61% | +36.75% | +12.17% | -19.64% |
| Rare Diseases '25: CNS/NeuroCNS/Neuro | 5 | $28.43B | $142.13B | -0.40% | -5.68% | -12.08% | -5.15% | +15.96% | +38.66% | -3.43% | +98.98% | -14.61% | +8.74% | +0.19% | +74.12% | +0.44% | +4.05% |
| Rare Diseases '25: Gene Therapy & Genetic MedGene Therapy & Genetic Med | 7 | $3.22B | $22.51B | +1.80% | -6.58% | -14.78% | -0.61% | +11.76% | -5.68% | +8.26% | -10.97% | -15.02% | -1.57% | +10.30% | +26.38% | +2.17% | -8.69% |
| Rare Diseases '25: Platform Biotechs & PipelinesPlatform Biotechs & Pipelines | 4 | $24.74B | $98.97B | -4.04% | -8.34% | -15.47% | -5.77% | +9.37% | +33.64% | +93.81% | +229.92% | -12.47% | +4.19% | +5.78% | +75.39% | +5.85% | -11.20% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary